Browsing: Stock

Amgen (NASDAQ:AMGN), the biotech heavyweight behind treatments for cancer, cardiovascular disease and other serious illnesses, gave investors another reason to cheer after posting a stronger-than-expected second quarter. Reuters reported revenue climbed 9% year over year to about $10.05 billion, while adjusted earnings landed at $6.29 per share, comfortably ahead of the $5.62 Wall Street consensus.…

The company’s obesity and diabetes franchise remained its biggest growth engine in the second quarter, with blockbuster GLP-1 drugs Mounjaro and Zepbound generating a combined $14.9 billion in revenue

to topclose Video This video is playing in picture-in-picture. On Air August 05, 2026 01:43 CLIP

What’s behind the move:The drug company raised its 2026 sales forecast after it saw strong demand for GLP-1 drugs in its fiscal second quarter

Healthcare AI expansion: Social media chatter highlights SoundHound AI’s recent deal where MUSC Health broadened deployment of its Emily AI agent into retail and specialty pharmacy services. Analysts on the platform note this move underscores the company’s push into enterprise healthcare applications amid broader AI adoption trends

Garmin Ltd. (Switzerland) stocks have been trading up by 19.42 percent amid strong demand for its advanced GPS wearables

Shares of Novo Nordisk fell in July after three consecutive months of gains, owing to a failure of its experimental drug in a late-stage trial, coupled with its lawsuit against rival Eli Lilly & Co

Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) are far and away the heavyweights in the global market for GLP-1 drugs, which effectively treat both type 2 diabetes and obesity

AsMedifast, Inc.MED prepares to unveil its second-quarter fiscal 2026 results on Aug. 03, after market close, investors are eager to see if the company can beat market expectations

Garmin Ltd.(NYSE:GRMN) stock climbed in Wednesday trading after the company reported stronger-than-expected second-quarter 2026 results, raised its full-year outlookand expanded margins